Archive

Title: The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast Date: October 2009 Authors: E A Rakha, M Aleskandarany, M E El-Sayed, R W Blamey, C W Elston, I O Ellis and A H S Lee European Journal of Cancer 2009; 45: 1780-1787 More Details

Title: Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Date: October 2009 Authors: Gilbert FG, Warren, RMI, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG, Leach MO. Radiology 2009;252:358-368 More Details

Title: A multicenter radomized trial of breast intensity-modulated radiation therapy to reduce acute dermatitis. Date: March 2009 Authors: Pignol J-P, Olivtto I, Rakovitch E. and Paszat L. J Clin Oncol 2008; 26:2085-2092. More Details

Title: Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Date: Aug. 5 2008 Authors: D. Puliti, G. Miccinesi, N. Collina et al. (the IMPACT Working Group). Br J Cancer 2008, 99(3): 423-427 More Details

Title: ECCO’s eLEARNING Programme Date: July 2008 Authors: More Details

Title: Unnecessary axillary node dissections in the sentinel lymph node era. Date: July 2008 Authors: M. Intra, N. Rotmensz, D. Mattar et al. EJC 2007 (43): 2664 - 2668. More Details

Title: Expression profiling technology: its contribution to our understanding of breast cancer. Date: July 2008 Authors: E A Rakha, M E El-Sayed, J S Reis-Filho1 & I O Ellis. Histopathology 2008, 52, 67–81. More Details

Title: Pattern of detection of locoregional recurrence in breast cancer: the Edinburgh experience. Date: July 2008 Authors: Montgomery DA, Krupa K, Jack WJL, Kerr GR, Kunkler IH, Thomas J, Dixon JM. British Journal of Cancer 2007; 96:1802-1807. More Details

Title: MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Date: July 2008 Authors: Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, Kuhn W, Schild HH. Lancet 2007; 370: 485-492. More Details

Title: Double-Blind, Randomized Placebo-Controlled Trial of Fulvestrant Compared With Exemestane After Prior Non-Steroidal Aromstase Inhibitor Therapy in Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer: Results from EFECT Date: April 2008 (ahead of print, March 3, 2008, jco.ascopubs.org) Authors: Stephen Chia, William Gradishar, Louis Mauriac et al. Journal Clin Oncol, Vol. 26, Nr. 10 More Details

Page 1 [2] [3]